Universe Pharmaceuticals (UPC) Total Current Liabilities: 2020-2024
- Universe Pharmaceuticals' Total Current Liabilities rose 47.68% to $20.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $20.3 million, marking a year-over-year increase of 47.68%. This contributed to the annual value of $20.3 million for FY2024, which is 47.68% up from last year.
- Latest data reveals that Universe Pharmaceuticals reported Total Current Liabilities of $20.3 million as of Q3 2024, which was down 1.44% from $20.6 million recorded in Q1 2024.
- In the past 5 years, Universe Pharmaceuticals' Total Current Liabilities ranged from a high of $8,001.4 billion in Q3 2020 and a low of $10.2 million during Q1 2022.
- Its 3-year average for Total Current Liabilities is $16.9 million, with a median of $17.0 million in 2023.
- Per our database at Business Quant, Universe Pharmaceuticals' Total Current Liabilities tumbled by 100.00% in 2021 and then soared by 127.68% in 2023.
- Universe Pharmaceuticals' Total Current Liabilities (Quarterly) stood at $8,001.4 billion in 2020, then crashed by 100.00% to $11.2 million in 2021, then grew by 16.83% to $13.1 million in 2022, then rose by 5.01% to $13.8 million in 2023, then skyrocketed by 47.68% to $20.3 million in 2024.
- Its Total Current Liabilities stands at $20.3 million for Q3 2024, versus $20.6 million for Q1 2024 and $13.8 million for Q3 2023.
